WATCH: Dr. Naomi Wolf Says the NIAID Wants to Remove the J&J COVID-19 Jab From the Marketplace Since They Don’t Have a Patent Like Moderna & Pfizer Jabs

Earlier this week, the CDC issued its recommendation to stop the Johnson & Johnson COVID-19 injection due to the risk of severe blood clots.

The agency noted their preference for the Moderna and Pfizer-BioNTech mRNA COVID-19 injections over the J&J jab.

Breaking: CDC advisory panel just voted to stop recommending j&j because of severe blood clot issues according to most recent data

This is why you don’t mandate vaccines before adequate safety data is available

— american fire wife (@mericanFireWife) December 16, 2021

The #CDC is considering whether it should stop use of the J&J COVID-19 #vaccine over cases of it causing blood clots, which have been seen more in young and middle aged women.

🔥WATCH @JoshJPhilipp's LIVE👉https://t.co/dcfr4g8zPV pic.twitter.com/SUV5ScVTkw

— Crossroads with Joshua Philipp (@crossroads_josh) December 17, 2021

This isn’t the first time the CDC has called for a temporary stoppage on the J&J COVID-19 jab.

The Western Journal explained:

The Johnson & Johnson vaccine is linked to a condition recognizable by rare blood clots — known as thrombosis with thrombocytopenia — in some patients who take it. The condition has been fatal in some cases.

After healthcare workers found the condition in six women, the CDC and FDA on April 13 recommended a temporary pause on the vaccine’s distribution. Around that month, 15 women had the condition, seven of whom had to be taken to the hospital. Three women died.

Public confidence in the Johnson & Johnson vaccine took a massive hit following the condition’s discovery, with a poll released that month showing that only a mere 22 percent of the population said they would take the vaccine.

But was the CDC’s recommendation based on public health or motivated by profits?

Dr. Naomi Wolf, a Rhodes Scholar and former Clinton Administration advisor, stated the NIAID influenced the move due to money.

Dr. Wolf appeared on Steve Bannon’s ‘The War Room’ and said the NIAID doesn’t hold patents on the J&J COVID-19 jab.

Thus, they’re not making any profits from the J&J jab.

Twitter continually giving me problems posting https://t.co/4e5MApcYCh

Naomi Wolf: NIAID Is Trying to Sideline the J&J Vaccines Because They Don’t Have a Patent on and Aren’t Making Money Off of Them like Pfizer and Moderna Vaccines (VIDEO)https://t.co/2t2RLL3I7g

— Gail Eiceman (@EicemanGail) December 18, 2021

Always #FollowTheMoney #BigPharma uses it's wholly-owned @FDA subsidiary to bully, intimidate & bankrupt any company having an EFFECTIVE drug that threatens THEIR profitability & monopoly.

No diff between corporate bureaucrats & govt 'regulators'. https://t.co/HHp87ROF7i

— Xťřåbíğģğ (@xtrabiggg) December 18, 2021

J&J shares plummeted following the CDC’s recommendation.

J&J shares nosedive after CDC announcement that its COVID vaccine CAN cause blood clots https://t.co/4Kr0brJMPL

— Wake Up UK (@StopNWO666) December 18, 2021

Gateway Pundit noted:

Naomi Wolf knows why. The NIAID doesn’t hold the patents of the J&J vaccine.

Naomi Wolf: Moderna and Pfizer have been trying to sideline Johnson&Johnson partly because as Rob Kennedy will tell you, the stakeholders at the NIAID don’t have a patent on and don’t make money on the J&J vaccine. So they want it out of the marketplace. It’s not the first time they’ve said, “Oh that bad J&J vaccine.” …Anyone who’s looked at VAERS and saw the thousands of blood clots and thrombotic events, strokes, thrombotic events, for Pfizer and Moderna as well as J&J, knows this is absolute ludicrisy.

Watch Dr. Naomi Wolf on The War Room: